Insys drug candidate an Orphan Drug for brain cancer

|About: Insys Therapeutics, Inc. (INSY)|By:, SA News Editor

The FDA designates Insys Therapeutics' (NASDAQ:INSY) pharmaceutical cannabidiol (CBD) an Orphan Drug for the treatment of glioblastoma multiforme, the most common and most aggressive form of brain tumor in humans.

Previously, the agency designated CBD an Orphan Drug for Lennox-Gastaut Syndrome and Dravet Syndrome.